Home Newsfeeds Calithera Biosciences Q2 Sales $3.00M, Same YoY

Calithera Biosciences Q2 Sales $3.00M, Same YoY

Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Calithera Biosciences (NASDAQ:CALA) reported $3.00 million in sales this quarter. This is the same as the same period last year.

Susquehanna Maintains Positive on Norwegian Cruise Line, Lowers Price Target to $15

By Benzinga Newsdesk

August 10, 10:28 AM

Susquehanna analyst Christopher Stathoulopoulos maintains Norwegian Cruise Line (NYSE:NCLH) with a Positive and lowers the price target from $20 to $15.

NCLH

Wynn Resorts To Rally Around 31%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin

May 17, 7:59 AM

Needham raised the price target for Stratasys Ltd. (NASDAQ: SSYS) from $15 to $19. Needham analyst James Ricchiuti maintained a Buy rating. Stratasys shares gained 9.7% to close at $15.80 on Tuesday.

BIDU